NOVARTIS EUROPHARM LIMITED
Get an alert when NOVARTIS EUROPHARM LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-06-19 (in 1mo)
Last made up 2025-06-05
Watchouts
Cash
—
Latest balance sheet
Net assets
—
Equity attributable
Employees
—
Average over period
Profit before tax
£29K
+348.5% vs 2023
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Material uncertainty over going concern
The management is currently working on a wind down plan for this entity. Therefore, the financial statements have been prepared on a non-going concern basis which the directors consider to be appropriate for the above-mentioned reasons. No specific accounting policies were affected by this decision.
Name history
Renamed 1 time since incorporation
- NOVARTIS EUROPHARM LIMITED 1997-03-26 → present
- CIBA EUROPHARM LIMITED 1995-06-14 → 1997-03-26
Profit before tax
2-year trend · vs Industrials median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | £36,584 | £41,031 | |
| Operating profit | £1,742 | £1,954 | |
| Profit before tax | -£11,841 | £29,423 | |
| Net profit | -£9,023 | £22,327 | |
| Cash | — | — | |
| Total assets less current liabilities | — | — | |
| Net assets | — | — | |
| Equity | £232,943 | £255,270 | |
| Average employees | — | — | |
| Wages | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | 4.8% | 4.8% | |
| Net margin | -24.7% | 54.4% | |
| Current ratio | 10.04x | 9.56x | |
| Interest cover | 0.13x | — |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102 §1A
- Reporting scope
- Standalone (parent only)
- Abridged
- Yes — abridged accounts (limited disclosure)
- Auditor
- KPMG LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Material uncertainty disclosed
“The management is currently working on a wind down plan for this entity. Therefore, the financial statements have been prepared on a non-going concern basis which the directors consider to be appropriate for the above-mentioned reasons. No specific accounting policies were affected by this decision.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 36 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| CULLEN, Richard Samuel | Secretary | 2026-01-01 | — | — |
| FOWLER, Edward Joseph | Director | 2016-09-27 | Apr 1976 | British |
| KAHLSTROEM, Johan Mikael Olof | Director | 2024-11-01 | Jul 1980 | Swedish |
Show 36 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| CULLEN, Richard Samuel | Secretary | 2021-01-01 | 2022-07-20 |
| HOLGATE, Benjamin James Michael | Secretary | 2011-06-22 | 2016-01-31 |
| JENNINGS, Sally Jane | Secretary | 2000-12-31 | 2008-03-11 |
| ROBERTS, Helen | Secretary | 2008-03-11 | 2011-06-22 |
| ROBINSON, Timothy William | Secretary | 2022-07-20 | 2026-01-01 |
| SHORTHOSE, Sally Jane | Secretary | 1997-09-01 | 2000-12-31 |
| STEWART, Ian Edmund Ferguson | Secretary | 1995-06-14 | 1997-09-01 |
| WESTON, Rebecca Ann | Secretary | 2016-02-01 | 2021-01-01 |
| ADAMS, Adrian | Director | 2001-01-23 | 2001-06-08 |
| AHMAD, Haseeb | Director | 2017-03-08 | 2021-04-01 |
| ARROCHA, Edgar Humberto | Director | 2014-09-04 | 2016-08-15 |
| BHATT, Chinmay Umesh | Director | 2021-04-01 | 2022-05-31 |
| BROOKS, Jason Mark | Director | 2019-05-01 | 2020-06-10 |
| COHARD-RADICE, Mariella | Director | 2008-08-29 | 2009-03-31 |
| CREBA, Judith, Dr | Director | 2006-11-30 | 2007-11-23 |
| DYER, Nora Christine | Director | 2007-11-23 | 2008-08-29 |
| DZAMBAZOSKA-CROWN, Janina | Director | 2021-11-02 | 2025-02-10 |
| FEUTREN, Gilles | Director | 2006-04-01 | 2008-04-30 |
| FULLAGAR, Edgar | Director | 1998-02-01 | 2002-04-23 |
| GAMACHE, Marie-Andree Renee | Director | 2022-06-29 | 2024-10-31 |
| GANNAWAY, David John | Director | 1995-06-14 | 1996-09-01 |
| GILBERT, David John | Director | 1998-10-21 | 2001-10-31 |
| JENKINS, William John, Dr | Director | 1995-06-14 | 1999-03-02 |
| KAPADIA, Sandipkumar Shantilal | Director | 2013-12-17 | 2014-09-04 |
| LACAZE, Oriane Fanny | Director | 2016-08-15 | 2019-05-01 |
| LONGMAN, Susan, Dr | Director | 2013-11-12 | 2021-11-02 |
| MAH, Seng Chin, Dr | Director | 1999-03-02 | 2006-04-01 |
| MATCHABA, Patrice | Director | 2009-05-18 | 2014-01-09 |
| MILANDER, John Harley, Doctor | Director | 1996-09-01 | 1998-10-21 |
| O'DOWD, Hugh Michael | Director | 2015-10-15 | 2016-09-16 |
| PARIS, William Drummond | Director | 2001-09-14 | 2005-04-22 |
| PELLIER, Gesa, Dr | Director | 2008-08-29 | 2013-11-12 |
| ROUSSEAU, Guy | Director | 2001-10-18 | 2006-11-01 |
| SAXENA, Subhanu | Director | 2005-04-22 | 2009-09-04 |
| TOUGAS, Gervais | Director | 2014-01-09 | 2020-06-10 |
| WEBB, Susan Ann | Director | 2009-09-04 | 2015-09-01 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Novartis Ag | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 162 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-01-05 | AP03 | officers | Appoint person secretary company with name date | |
| 2026-01-05 | TM02 | officers | Termination secretary company with name termination date | |
| 2025-09-15 | AA | accounts | Accounts with accounts type full | |
| 2025-06-17 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-02-12 | TM01 | officers | Termination director company with name termination date | |
| 2025-01-14 | CH01 | officers | Change person director company with change date | |
| 2024-11-05 | AP01 | officers | Appoint person director company with name date | |
| 2024-11-04 | TM01 | officers | Termination director company with name termination date | |
| 2024-06-05 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-05-30 | AA | accounts | Accounts with accounts type full | |
| 2023-08-22 | AA | accounts | Accounts with accounts type full | |
| 2023-06-19 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-09-14 | AA | accounts | Accounts with accounts type full | |
| 2022-07-26 | AP03 | officers | Appoint person secretary company with name date | |
| 2022-07-25 | TM02 | officers | Termination secretary company with name termination date | |
| 2022-07-05 | AP01 | officers | Appoint person director company with name date | |
| 2022-06-29 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-06-06 | TM01 | officers | Termination director company with name termination date | |
| 2021-11-04 | AP01 | officers | Appoint person director company with name date | |
| 2021-11-03 | TM01 | officers | Termination director company with name termination date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 4
- Capital events
- 0
- Officers appointed
- 1
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
+12.2%
£36,584 £41,031
-
Cash
—
Not reported
-
Net assets
—
Not reported
-
Employees
—
Not reported
-
Operating profit
+12.2%
£1,742 £1,954
-
Profit before tax
+348.5%
-£11,841 £29,423
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers